Growth Metrics

Pfizer (PFE) Goodwill & Intangibles (2016 - 2025)

Pfizer (PFE) has disclosed Goodwill & Intangibles for 17 consecutive years, with $69.1 billion as the latest value for Q3 2025.

  • On a quarterly basis, Goodwill & Intangibles rose 0.77% to $69.1 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $69.1 billion, a 0.77% increase, with the full-year FY2023 number at $132.7 billion, up 40.04% from a year prior.
  • Goodwill & Intangibles was $69.1 billion for Q3 2025 at Pfizer, up from $68.4 billion in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $132.7 billion in Q4 2023 to a low of $49.9 billion in Q3 2021.
  • A 5-year average of $76.2 billion and a median of $68.8 billion in 2024 define the central range for Goodwill & Intangibles.
  • Peak YoY movement for Goodwill & Intangibles: dropped 14.68% in 2021, then skyrocketed 40.04% in 2023.
  • Pfizer's Goodwill & Intangibles stood at $74.4 billion in 2021, then increased by 27.42% to $94.7 billion in 2022, then surged by 40.04% to $132.7 billion in 2023, then crashed by 48.32% to $68.6 billion in 2024, then grew by 0.77% to $69.1 billion in 2025.
  • Per Business Quant, the three most recent readings for PFE's Goodwill & Intangibles are $69.1 billion (Q3 2025), $68.4 billion (Q1 2025), and $68.6 billion (Q3 2024).